Pacira Pharmaceuticals Aktie
WKN DE: A1H68T / ISIN: US6951271005
28.02.2025 04:24:09
|
Pacira BioSciences Acquires Remaining 81% Equity Stake Of GQ Bio Therapeutics For About $32 Mln
(RTTNews) - Pacira BioSciences Inc. (PCRX) said that it has acquired the remaining 81 percent equity stake of GQ Bio Therapeutics GmbH for about $32 million, net of working capital and other transaction adjustments, to equity holders other than Pacira. The net purchase price includes $18 million of cash paid at closing, $8 million to be paid over three years pursuant to a key employee holdback agreement and a post-closing indemnity holdback of $6 million.
GQ Bio is a privately held biopharmaceutical company with a novel, high-capacity, local-delivery platform that makes genetic medicines more efficient and enables the use of large and multiple gene constructs. GQ Bio also brings to Pacira a preclinical portfolio of assets with disease-modifying potential in prevalent musculoskeletal diseases, and research and development talent, Pacira said.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Pacira Pharmaceuticals Inc.mehr Nachrichten
07.05.25 |
Ausblick: Pacira Pharmaceuticals mit Zahlen zum abgelaufenen Quartal (finanzen.net) |
Analysen zu Pacira Pharmaceuticals Inc.mehr Analysen
Aktien in diesem Artikel
Pacira Pharmaceuticals Inc. | 21,40 | 0,94% |
|